Hospital Chain HCA Prohibits Power Morcellation for Uterine Fibroids
One of the nation's largest hospital networks said it is halting use of a power tool commonly used in gynecological surgery after the U.S. Food and Drug Administration warned it can spread cancer.
The move by HCA Holdings, a for-profit chain with about 160 hospitals and 115 surgery centers in 20 states, marks one of the first significant shifts around the laparoscopic power morcellator since the FDA warning. The agency said Monday the tool shouldn't be used in the "vast majority" of women undergoing surgery for common growths called fibroids because the procedure could spread and worsen hidden cancers.
(Could be big trouble for Johnson & Johnson- it's not longer being sold but there has yet to be a recall of devices already in the market and I'm thinking of the lawsuits, too) MG
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.